HCWB vs NBIX · rev $6.7M vs P/E 45, rev $1.77B
HCW Biologics Inc (HCWB) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
HCW Biologics Inc (HCWB) is a biotechnology company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HCWB revenue for 2026-06-30 was $6.7M. Net income was -$1.7M. Revenue was up 2.3% from 2026-03-31 to 2026-06-30. HCWB currently screens at market cap $14.2M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
HCWB currently screens at market cap $14.2M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the HCWB and NBIX stock pages for the full models.
Not investment advice.